The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control

Vaccines against Japanese encephalitis (JE) have been available for decades. Currently, most JE-endemic countries have vaccination programs for their at-risk populations. Even so, JE remains the leading recognized cause of viral encephalitis in Asia. In 2018, the U.S. Centers for Disease Control and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kirsten S. Vannice, Susan L. Hills, Lauren M. Schwartz, Alan D. Barrett, James Heffelfinger, Joachim Hombach, G. William Letson, Tom Solomon, Anthony A. Marfin, the Japanese encephalitis vaccination experts panel
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/0f0d7e8409a3466190711403f7c6bec4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0f0d7e8409a3466190711403f7c6bec4
record_format	dspace
spelling	oai:doaj.org-article:0f0d7e8409a3466190711403f7c6bec42021-12-02T17:39:45ZThe future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control10.1038/s41541-021-00338-z2059-0105https://doaj.org/article/0f0d7e8409a3466190711403f7c6bec42021-06-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00338-zhttps://doaj.org/toc/2059-0105Vaccines against Japanese encephalitis (JE) have been available for decades. Currently, most JE-endemic countries have vaccination programs for their at-risk populations. Even so, JE remains the leading recognized cause of viral encephalitis in Asia. In 2018, the U.S. Centers for Disease Control and Prevention and PATH co-convened a group of independent experts to review JE prevention and control successes, identify remaining scientific and operational issues that need to be addressed, discuss opportunities to further strengthen JE vaccination programs, and identify strategies and solutions to ensure sustainability of JE control during the next decade. This paper summarizes the key discussion points and recommendations to sustain and expand JE control.Kirsten S. VanniceSusan L. HillsLauren M. SchwartzAlan D. BarrettJames HeffelfingerJoachim HombachG. William LetsonTom SolomonAnthony A. Marfinthe Japanese encephalitis vaccination experts panelNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Kirsten S. Vannice Susan L. Hills Lauren M. Schwartz Alan D. Barrett James Heffelfinger Joachim Hombach G. William Letson Tom Solomon Anthony A. Marfin the Japanese encephalitis vaccination experts panel The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
description	Vaccines against Japanese encephalitis (JE) have been available for decades. Currently, most JE-endemic countries have vaccination programs for their at-risk populations. Even so, JE remains the leading recognized cause of viral encephalitis in Asia. In 2018, the U.S. Centers for Disease Control and Prevention and PATH co-convened a group of independent experts to review JE prevention and control successes, identify remaining scientific and operational issues that need to be addressed, discuss opportunities to further strengthen JE vaccination programs, and identify strategies and solutions to ensure sustainability of JE control during the next decade. This paper summarizes the key discussion points and recommendations to sustain and expand JE control.
format	article
author	Kirsten S. Vannice Susan L. Hills Lauren M. Schwartz Alan D. Barrett James Heffelfinger Joachim Hombach G. William Letson Tom Solomon Anthony A. Marfin the Japanese encephalitis vaccination experts panel
author_facet	Kirsten S. Vannice Susan L. Hills Lauren M. Schwartz Alan D. Barrett James Heffelfinger Joachim Hombach G. William Letson Tom Solomon Anthony A. Marfin the Japanese encephalitis vaccination experts panel
author_sort	Kirsten S. Vannice
title	The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
title_short	The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
title_full	The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
title_fullStr	The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
title_full_unstemmed	The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
title_sort	future of japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal je control
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/0f0d7e8409a3466190711403f7c6bec4
work_keys_str_mv	AT kirstensvannice thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT susanlhills thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT laurenmschwartz thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT alandbarrett thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT jamesheffelfinger thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT joachimhombach thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT gwilliamletson thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT tomsolomon thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT anthonyamarfin thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT thejapaneseencephalitisvaccinationexpertspanel thefutureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT kirstensvannice futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT susanlhills futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT laurenmschwartz futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT alandbarrett futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT jamesheffelfinger futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT joachimhombach futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT gwilliamletson futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT tomsolomon futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT anthonyamarfin futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol AT thejapaneseencephalitisvaccinationexpertspanel futureofjapaneseencephalitisvaccinationexpertrecommendationsforachievingandmaintainingoptimaljecontrol
_version_	1718379808052740096

The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control

Ejemplares similares